השרייה של סבילות חיסונית על ידי מתוטרקסט
- 专利权人:
- GENZYME CORPORATION
- 发明人:
- 申请号：
- IL22924513
- 公开号：
- IL229245D0
- 申请日:
- 2013.11.04
- 申请国别(地区):
- IL
- 年份:
- 2014
- 代理人:
- 摘要：
- The invention provides methods for reducing undesired immune responses, such as anti-drug antibody (ADA) responses and other T- and/or B-cell-mediated immune responses, in patients by using treatment with methotrexate.
- 来源网站：
- 中国工程科技知识中心
